Alexey Terskikh, PhD, Chief Scientific Officer of Stelvio will be presenting in the track titled "Epigenetic Enzymes in Drug discovery" and in the session "Epigenetic Modification & Transcriptional Regulation." For more information, please visit the conference website: https://www.gtcbio.com/conferences/enzymes-drug-discovery-summit/?section=fullagenda